Antonio Gasbarrini

Research interests

Publications

• Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

  Annals of Oncology · 2024 · https://doi.org/10.1016/j.annonc.2024.02.005

• Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota

  Nutrients · 2023 · https://doi.org/10.3390/nu15092211

• Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report

  Gut · 2022 · https://doi.org/10.1136/gutjnl-2022-327745

• Intestinal Barrier in Human Health and Disease

  International Journal of Environmental Research and Public Health · 2021 · 10.3390/ijerph182312836

• Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study

  Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.03555

• Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis

  Gastroenterology · 2021 · https://doi.org/10.1053/j.gastro.2021.04.012

• Systematic review: gastric microbiota in health and disease

  Alimentary Pharmacology & Therapeutics · 2020 · https://doi.org/10.1111/apt.15650

• European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients

  Gut · 2020 · https://doi.org/10.1136/gutjnl-2020-321372

• What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases

  Microorganisms · 2019 · https://doi.org/10.3390/microorganisms7010014

• Gut Microbial, Inflammatory and Metabolic Signatures in Older People with Physical Frailty and Sarcopenia: Results from the BIOSPHERE Study

  Nutrients · 2019 · https://doi.org/10.3390/nu12010065

• Cancer and Mediterranean Diet: A Review

  Nutrients · 2019 · 10.3390/nu11092059

• International consensus conference on stool banking for faecal microbiota transplantation in clinical practice

  Gut · 2019 · 10.1136/gutjnl-2019-319548

• Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition

  Nutrients · 2019 · 10.3390/nu11102393

• Actinobacteria: A relevant minority for the maintenance of gut homeostasis

  Digestive and Liver Disease · 2018 · 10.1016/j.dld.2018.02.012

• Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

  The Lancet · 2018 · 10.1016/s0140-6736(18)30840-7

• Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease

  Hepatology · 2018 · https://doi.org/10.1002/hep.30036

• European consensus conference on faecal microbiota transplantation in clinical practice

  Gut · 2017 · https://doi.org/10.1136/gutjnl-2016-313017

• Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report

  Gut · 2016 · https://doi.org/10.1136/gutjnl-2016-312288

• Antibiotics as deep modulators of gut microbiota: between good and evil

  Gut · 2016 · 10.1136/gutjnl-2016-312297

• Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

  Alimentary Pharmacology & Therapeutics · 2015 · 10.1111/apt.13144

• Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study

  Journal of Hepatology · 2014 · https://doi.org/10.1016/j.jhep.2014.10.037

• The role of small intestinal bacterial overgrowth in Parkinson's disease

  Movement Disorders · 2013 · https://doi.org/10.1002/mds.25522

• Commensal Clostridia: leading players in the maintenance of gut homeostasis

  Gut Pathogens · 2013 · 10.1186/1757-4749-5-23

• Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: Multicentre, open-label, phase II safety study

  European Journal of Cancer · 2013 · https://doi.org/10.1016/j.ejca.2013.05.028

• Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study

  The Lancet Oncology · 2012 · 10.1016/s1470-2045(12)70490-4

• Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial

  Hepatology · 2012 · 10.1002/hep.26185

• Prevalence of Small Intestinal Bacterial Overgrowth in Parkinson's Disease

  Movement Disorders · 2011 · https://doi.org/10.1002/mds.23566

• Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study

  The American Journal of Gastroenterology · 2010 · https://doi.org/10.1038/ajg.2010.218

• Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease†

  Hepatology · 2009 · https://doi.org/10.1002/hep.22848

• Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis

  Journal of Hepatology · 2009 · https://doi.org/10.1016/j.jhep.2009.06.008

• Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study

  The Lancet · 2007 · 10.1016/s0140-6736(07)61814-5

• Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis

  Alimentary Pharmacology & Therapeutics · 2006 · 10.1111/j.1365-2036.2006.02927.x

• Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis

  Alimentary Pharmacology & Therapeutics · 2006 · 10.1111/j.1365-2036.2006.02927.x

• TNF-α Blockade Down-Regulates the CD40/CD40L Pathway in the Mucosal Microcirculation: A Novel Anti-Inflammatory Mechanism of Infliximab in Crohn’s Disease

  The Journal of Immunology · 2006 · https://doi.org/10.4049/jimmunol.176.4.2617

• Angiogenesis as a Novel Component of Inflammatory Bowel Disease Pathogenesis

  Gastroenterology · 2006 · https://doi.org/10.1053/j.gastro.2006.03.054

• Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori

  The Lancet · 1998 · 10.1016/s0140-6736(05)60004-9

• Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori

  The Lancet · 1998 · 10.1016/s0140-6736(05)60004-9

Current projects

No projects listed.